Avanafil
1 NDC across 1 manufacturer|1 Generic,0 Brand
Avanafil is used to treat erectile dysfunction, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 27, 2012, and the first generic was approved Jun 14, 2024. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient.
Avanafil is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $49.48 to $49.48 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
1G / 0B
Manufacturers
1
competing in market
Price Spread
$49.48 – $49.48
per EA
7d Activity
avg +0.9% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing AVANAFIL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
AVANAFIL 200 MG TABLET | $49.4833 per EA | +0.94% |
Frequently Asked Questions
What is Avanafil used to treat?
Avanafil is used to treat erectile dysfunction, per the National Library of Medicine's MED-RT classification.
When did Avanafil become available as a generic?
FDA approved the first generic Avanafil (ANDA) on Jun 14, 2024. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Avanafil products are on the market?
The Avanafil drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.
What is the price range for Avanafil?
NADAC reference prices for Avanafil range from $49.4833 to $49.4833 per EA.
Which manufacturers make Avanafil?
1 manufacturer lists Avanafil in NADAC. Ranked by number of NDCs, the largest are Camber Pharmaceuticals Inc. (1).
How has the price of Avanafil changed recently?
Over the past 7 days, 1 Avanafil NDC rose and 0 fell, with a market-wide average change of +0.9%.